DBV Technologies SA (DBVT)
18.18
-0.39
(-2.10%)
USD |
NASDAQ |
May 22, 16:00
18.23
+0.05
(+0.28%)
After-Hours: 20:00
DBV Technologies EPS Diluted (Quarterly) : -0.5577 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cellectis SA | -0.1774 |
| Akari Therapeutics Plc | -9.584 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -1.28 |
| Autolus Therapeutics Plc | -0.2686 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -47.77M |
| Total Expenses (Quarterly) | 47.77M |
| Enterprise Value | 786.24M |
| Earnings Yield | -24.82% |
| Normalized Earnings Yield | -24.82 |